FDA | What's New
Follow
Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - 03/05/2024
On March 5th, 2024, FDA is conducting a public workshop to discuss aspects of complex adaptive, Bayesian, and other novel clinical trial designs. This meeting is being conducted to meet the performance goal of convening a public workshop on complex innovative design (CID) included in the seventh authorization of the Prescription Drug User Fee Act